Skip to main content
. 2017 Sep 26;314(2):E105–E114. doi: 10.1152/ajpendo.00153.2017

Table 2.

Intramyocellular sphingolipid concentrations during the postprandial protocol

Postprandial Period
1.5 h 6.5 h P Value
SS fraction, pmol/mg protein
    Sphingosine 0.85 (0.58–1.25) 0.83 (0.65–1.18) 0.994
    Sphinganine 0.81 ± 0.42 0.81 ± 0.54 0.993
    Total Cer 73.8 ± 28.0 80.1 ± 26.0 0.262
    C14:0 Cer 0.27 ± 0.12 0.25 ± 0.12 0.202
    C16:0 Cer 9.5 ± 5.2 8.0 ± 2.8 0.062
    C18:1 Cer 5.3 (4.0–7.2) 4.9 (3.4–6.7) 0.056
    C18:0 Cer 35.0 ± 12.0 30.8 ± 10.5 0.035
    C20:0 Cer 0.99 ± 0.27 0.96 ± 0.41 0.608
    C24:1 Cer 4.2 ± 3.5 7.5 ± 5.3 0.0016
    C24:0 Cer 17.0 ± 12.8 27.5 ± 12.7 0.0016
IMF fraction, pmol/mg protein
    Sphingosine 0.69 (0.51–1.03) 0.74 (0.47–1.57) 0.592
    Sphinganine 0.71 ± 0.42 0.73 ± 0.43 0.735
    Total Cer 44.8 (37.0–54.9) 46.1 (35.6–55.9) 0.483
    C14:0 Cer 0.31 ± 0.15 0.34 ± 0.24 0.233
    C16:0 Cer 5.5 ± 2.0 5.8 ± 3.1 0.414
    C18:1 Cer 5.5 (4.3–7.6) 5.4 (3.9–8.0) 0.922
    C18:0 Cer 18.7 ± 8.7 19.1 ± 9.4 0.769
    C20:0 Cer 0.10 (0.07–0.24) 0.09 (0.07–0.21) 0.492
    C24:1 Cer 1.8 (1.4–2.5) 1.7 (1.4–2.4) 0.115
    C24:0 Cer 14.0 (9.8–15.4) 13.0 (10.1–17.9) 0.053

Data are shown as means ± SD or median (interquartile range). Analyzed by paired t-test or Wilcoxon signed rank test. SS, subsarcolemmal; IMF, intramyofibrillar; Cer, ceramide.